DT
Denali Therapeutics Inc
🇺🇸XNAS.DNLIUnited StatesHealthcare
$20.51USDdown -0.71 (-3.35%)OpenEnd of day5:39 PM
Price$20.51-0.71 (-3.35%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US24823R1059
- CUSIP
- 24823R105
Company
- Employees
- 503
- Headquarters
- South San Francisco, United States
- CEO
- Dr. Ryan J. Watts Ph.D.
Market
- Shares outstanding
- 159.8M
- Market cap
- $3.28B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $3.28B
- EPS LTM
- -$3.20calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -6.41calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.6M+100%up year on year
- Net income
- -$511.45M-6.77%down year on year
- Gross margin
- -2,889.84%
- Free cash flow
- -$437.46M-18.89%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.